Trump's threat of imposing a tariff on Denmark over desires to acquire Greenland has caught the attention of one of the ...

There is no sign of a slowdown in Johnston County's rapid growth, meaning things like cost of living and infrastructure are ...

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

Finally, some good news for Novo Nordisk (NYSE: NVO) shareholders! Twice in the past two months, the Danish manufacturer of GLP-1 drugs for weight loss and diabetes treatment has reported clinical ...

Novo Nordisk is facing serious pressure from a powerful adversary. It still has plenty of leeway to penetrate its target market, for now. Investors should keep a close eye on this company.

With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO). A Scandinavian economic behemoth ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is primarily manufactured in Denmark, although Novo Nordisk has some manufacturing capacity in Clayton, North Carolina. It's likely ...

although Novo Nordisk has some manufacturing capacity in Clayton, North Carolina. It's likely, therefore, that steep tariffs on products imported to the U.S. from Denmark would cause the prices of ...